e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 7, 2010
Ardea Biosciences, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
1-33734
|
|
94-3200380 |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
| 4939 Directors Place |
|
92121 |
| San Diego, California
|
|
(Zip Code) |
| (Address of principal executive offices)
|
|
|
Registrant’s telephone number, including area code: (858) 652-6500
Not applicable.
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
| |
|
|
|
|
Item 7.01. Regulation FD Disclosure |
|
|
|
|
Item 9.01. Financial Statements and Exhibits |
|
|
|
|
SIGNATURE |
|
|
|
|
EXHIBIT LIST |
|
|
|
|
EXHIBIT 99.1 |
|
|
|
|
Item 7.01. Regulation FD Disclosure
Ardea Biosciences, Inc. (the “Company”) has recently received and publicly announced certain
clinical data related to its products. A copy of the press release announcing the data is
furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety.
The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth
by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:
| |
|
|
| Exhibit |
|
|
| Number |
|
Document Description |
99.1
|
|
Press release dated January 7, 2010. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
|
|
|
|
| |
ARDEA BIOSCIENCES, INC.
|
|
| Date: January 7, 2010 |
/s/ CHRISTIAN WAAGE
|
|
| |
Christian Waage |
|
| |
General Counsel |
|
| |
EXHIBIT LIST
| |
|
|
| Exhibit |
|
|
| Number |
|
Document Description |
99.1
|
|
Press release dated January 7, 2010. |